REPL
Replimune Group, Inc.
NASDAQHealthcareBiotechnologyUS
USD11.00
+0.49 (+4.66%)
Rating:C-
Company Profile
CEO
Sushil Patel
IPO Date
2018-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$10.76
Prev. Close
$10.51
Day Low
$10.38
Day High
$11.18
52W Low
$1.50
52W High
$12.50
Market Cap
$0.92B
Volume
4.07M